These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32190695)

  • 61. The Role of Gut Microbiota and Microbiota-Related Serum Metabolites in the Progression of Diabetic Kidney Disease.
    Zhang Q; Zhang Y; Zeng L; Chen G; Zhang L; Liu M; Sheng H; Hu X; Su J; Zhang D; Lu F; Liu X; Zhang L
    Front Pharmacol; 2021; 12():757508. PubMed ID: 34899312
    [No Abstract]   [Full Text] [Related]  

  • 62. Untargeted Metabolomic Plasma Profiling of Emirati Dialysis Patients with Diabetes versus Non-Diabetic: A Pilot Study.
    Banimfreg BH; Alshraideh H; Shamayleh A; Guella A; Semreen MH; Al Bataineh MT; Soares NC
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883517
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Association of Glomerular Complement C4c Deposition With the Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes.
    Duan S; Sun L; Nie G; Chen J; Zhang C; Zhu H; Huang Z; Qian J; Zhao X; Xing C; Zhang B; Yuan Y
    Front Immunol; 2020; 11():2073. PubMed ID: 32983156
    [No Abstract]   [Full Text] [Related]  

  • 64. Serum myeloid-related protein 8/14 is a potential predictor of diabetic kidney disease.
    Gu W; Cui J; Shi M; Zhang R; Tan D; Zhang X; Zhang H
    Discov Med; 2020; 30(160):97-105. PubMed ID: 33382965
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Could serum zonulin be an intestinal permeability marker in diabetes kidney disease?
    Carpes LS; Nicoletto BB; Canani LH; Rheinhemer J; Crispim D; Souza GC
    PLoS One; 2021; 16(6):e0253501. PubMed ID: 34170951
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Metabolomics: A New Tool to Reveal the Nature of Diabetic Kidney Disease.
    Huang G; Li M; Li Y; Mao Y
    Lab Med; 2022 Nov; 53(6):545-551. PubMed ID: 35748329
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Serum hemoglobin concentration and risk of renal function decline in early stages of diabetic kidney disease: a nationwide, biopsy-based cohort study.
    Yamanouchi M; Furuichi K; Shimizu M; Toyama T; Yamamura Y; Oshima M; Kitajima S; Hara A; Iwata Y; Sakai N; Oba Y; Matsuoka S; Ikuma D; Mizuno H; Suwabe T; Hoshino J; Sawa N; Yuzawa Y; Kitamura H; Suzuki Y; Sato H; Uesugi N; Ueda Y; Nishi S; Yokoyama H; Nishino T; Samejima K; Kohagura K; Shibagaki Y; Makino H; Matsuo S; Ubara Y; Wada T
    Nephrol Dial Transplant; 2022 Feb; 37(3):489-497. PubMed ID: 34028524
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Urine Metabolomics Analysis in Patients With Normoalbuminuric Diabetic Kidney Disease.
    Feng Q; Li Y; Yang Y; Feng J
    Front Physiol; 2020; 11():578799. PubMed ID: 33123032
    [TBL] [Abstract][Full Text] [Related]  

  • 69. 5-Hydroxyhexanoic Acid Predicts Early Renal Functional Decline in Type 2 Diabetes Patients with Microalbuminuria.
    Tang X; You J; Liu D; Xia M; He L; Liu H
    Kidney Blood Press Res; 2019; 44(2):245-263. PubMed ID: 31071709
    [TBL] [Abstract][Full Text] [Related]  

  • 70.
    Li Y; Jin L; Yan J; Zhang H; Zhang R; Hu C
    Mediators Inflamm; 2021; 2021():5521050. PubMed ID: 33958973
    [TBL] [Abstract][Full Text] [Related]  

  • 71. High-Resolution Tandem Mass Spectrometry Identifies a Particular Ganglioside Pattern in Early Diabetic Kidney Disease of Type 2 Diabetes Mellitus Patients.
    Suteanu-Simulescu A; Zamfir AD; Ica R; Sarbu M; Munteanu CVA; Gadalean F; Vlad A; Bob F; Jianu DC; Petrica L
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35566027
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Long-term outcomes of patients with type 2 diabetes attending a multidisciplinary diabetes kidney disease clinic.
    Low S; Lim SC; Wang J; Yeoh LY; Liu YL; Lim EK; Shao YL; Chui W; Fun S; Chua CL; Subramaniam T; Sum CF
    J Diabetes; 2018 Jul; 10(7):572-580. PubMed ID: 29154443
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Multidisciplinary management of diabetic kidney disease: a systematic review and meta-analysis.
    Helou N; Dwyer A; Shaha M; Zanchi A
    JBI Database System Rev Implement Rep; 2016 Jul; 14(7):169-207. PubMed ID: 27532796
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Association of blood glucose and renal end points in advanced diabetic kidney disease.
    Kornelius E; Lo SC; Huang CN; Wang YH; Yang YS
    Diabetes Res Clin Pract; 2020 Mar; 161():108011. PubMed ID: 31991151
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Association of Serum Amyloid A with Kidney Outcomes and All-Cause Mortality in American Indians with Type 2 Diabetes.
    Saulnier PJ; Dieter BP; Tanamas SK; McPherson SM; Wheelock KM; Knowler WC; Looker HC; Meek RL; Nelson RG; Tuttle KR
    Am J Nephrol; 2017; 46(4):276-284. PubMed ID: 28934744
    [TBL] [Abstract][Full Text] [Related]  

  • 76. An evaluation of the diabetic kidney disease definition in chinese patients diagnosed with type 2 diabetes mellitus.
    Lu B; Gong W; Yang Z; Yang Z; Yang Y; Wen J; Zhao N; Zhu X; Hu R
    J Int Med Res; 2009; 37(5):1493-500. PubMed ID: 19930856
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Validation of a protein biomarker test for predicting renal decline in type 2 diabetes: The Fremantle Diabetes Study Phase II.
    Peters KE; Davis WA; Ito J; Bringans SD; Lipscombe RJ; Davis TME
    J Diabetes Complications; 2019 Dec; 33(12):107406. PubMed ID: 31669066
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Urinary peptidomics and bioinformatics for the detection of diabetic kidney disease.
    Brondani LA; Soares AA; Recamonde-Mendoza M; Dall'Agnol A; Camargo JL; Monteiro KM; Silveiro SP
    Sci Rep; 2020 Jan; 10(1):1242. PubMed ID: 31988353
    [TBL] [Abstract][Full Text] [Related]  

  • 79. MicroRNAs: new biomarkers and promising therapeutic targets for diabetic kidney disease.
    Nascimento LRD; Domingueti CP
    J Bras Nefrol; 2019; 41(3):412-422. PubMed ID: 30742700
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Circulating microparticles levels are increased in patients with diabetic kidney disease: A case-control research.
    Rodrigues KF; Pietrani NT; Fernandes AP; Bosco AA; de Sousa MCR; de Fátima Oliveira Silva I; Silveira JN; Campos FMF; Gomes KB
    Clin Chim Acta; 2018 Apr; 479():48-55. PubMed ID: 29305843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.